Ichnos Glenmark Innovation
Blood & Organ Banks · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1 World Trade Ctr Fl 76 Ste D, New York,...Website
www.iginnovate.comRevenue
<$5 MillionIndustry
About Ichnos Glenmark Innovation
IGI, Inc. is a global, fully integrated clinical-stage biotechnology company focused on developing innovative biologics in oncology. Headquartered in New York, NY, IGI is advancing a robust pipeline of novel, first-in-class Multispecifics aimed at addressing complex diseases and treating patients holistically. Powered by its proprietary BEAT® technology platform, IGI is committed to delivering breakthrough, curative therapies to improve and extend the lives of patients battling hematological malignancies and solid tumors.Explore more
SIC Code 28,283NAICS Code 32,325Show moreIchnos Glenmark Innovation Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Ichnos Glenmark Innovation Tech Stack
A closer look at the technologies used by Ichnos Glenmark Innovation
See more technologies
Top Blood & Organ Banks Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ichnos Glenmark Innovation
Sign Up For FreeTo access detailed company insights
IGI, Inc. is a global, fully integrated clinical-stage biotechnology company focused on developing innovative biologics in oncology. Headquartered in New York, NY, IGI is advancing a robust pipeline of novel, first-in-class Multispecifics aimed at addressing complex diseases and treating patients holistically. Powered by its proprietary BEAT® techn... Read More
